Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.292 USD | +1.84% | -0.37% | +1.84% |
Feb. 06 | Knight Therapeutics Announces Launch of Bijuva in Canada | MT |
Jan. 04 | Knight Therapeutics Announces Product Launch For IMVEXXY In Canada | MT |
Chart calendar TherapeuticsMD, Inc.
Upcoming events on TherapeuticsMD, Inc.
Past events on TherapeuticsMD, Inc.
2023-11-14 04:05 pm | Q3 2023 Earnings Release |
2023-08-14 06:50 am | Q2 2023 Earnings Release |
2023-06-26 08:00 am | Annual General Meeting |
2023-05-15 04:05 pm | Q1 2023 Earnings Release |
2023-04-07 04:01 pm | Q4 2022 Earnings Release |
2022-11-14 04:05 pm | Q3 2022 Earnings Release |
2022-08-15 08:30 am | Interim 2022 Earnings Call |
2022-08-15 06:50 am | Interim 2022 Earnings Release |
2022-05-16 04:30 pm | Q1 2022 Earnings Call |
2022-05-16 04:05 pm | Q1 2022 Earnings Release |
2022-03-10 08:30 am | FY 2021 Earnings Call |
2022-03-10 06:50 am | FY 2021 Earnings Release |
2021-11-11 08:30 am | Q3 2021 Earnings Call |
2021-11-11 06:50 am | Q3 2021 Earnings Release |
2021-08-04 08:30 am | Interim 2021 Earnings Call |
2021-08-04 06:50 am | Interim 2021 Earnings Release |
2021-05-27 08:00 am | Annual General Meeting |
2021-05-06 08:30 am | Q1 2021 Earnings Call |
2021-05-06 07:00 am | Q1 2021 Earnings Release |
2021-03-09 11:00 am | H.C. Wainwright Global Life Science Conference |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 16,1 15,7 2.74% | 49,6 41,4 19.86% | 64,9 63,3 2.43% | 87,0 97,3 -10.62% | 70,0 92,6 -24.45% |
EBITDA Million USD | Released Forecast Spread | -130 -130 0.3% | -151 -152 0.68% | -154 -141 -9.4% | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -130 -132 1.01% | -151 -152 0.5% | -156 -144 -8.33% | -140 -131 -6.29% | 1,19 -73,5 101.62% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -133 -133 0.51% | -176 -176 -0.22% | -184 -171 -7.57% | -172 -163 -5.71% | 1,07 23,8 -95.49% |
Net income Million USD | Released Forecast Spread | -133 -133 0.45% | -176 -176 -0.23% | -184 -171 -7.57% | -172 -163 -5.71% | 112 23,5 376.58% |
EPS USD | Released Forecast Spread | -29,5 -29,1 -1.25% | -36,0 -34,9 -3.16% | -33,5 -30,5 -9.84% | -21,5 -20,2 -6.61% | 12,0 2,47 384.21% |
Announcement Date | 21/02/19 | 20/02/20 | 02/03/21 | 10/03/22 | 08/04/23 |
Quarterly results
Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 25,4 25,9 -1.8% | 18,7 29,4 -36.45% | 19,3 18,0 7.67% | 28,6 23,2 23.11% | 20,9 30,2 -30.74% | 1,15 23,8 -95.16% | 0,42 1,70 -75.53% | 0,44 0,50 -12.6% |
EBITDA Million USD | Released Forecast Spread | -38,9 -33,0 -17.98% | |||||||
EBIT Million USD | Released Forecast Spread | -39,9 -33,3 -19.94% | -35,4 -26,7 -32.35% | -26,2 -27,5 4.51% | -18,8 -23,5 19.99% | 67,0 -7,70 970.23% | -2,67 0,70 -481% | -2,47 -0,70 -253.14% | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -47,4 -39,7 -19.55% | -43,0 -33,3 -29.06% | -49,0 -34,0 -44.05% | 113 -26,4 527.67% | -33,5 -10,8 -210.29% | -2,31 0,70 -430% | -2,41 -0,70 -244.86% | |
Net income Million USD | Released Forecast Spread | -47,4 -39,7 -19.55% | -43,0 -33,3 -29.06% | -49,0 -34,0 -44.05% | 112 -26,4 525.58% | 77,7 -10,8 819.46% | -3,60 0,60 -700.5% | -2,41 -0,70 -244.86% | |
EPS USD | Released Forecast Spread | -5,50 -5,00 -10% | -5,00 -3,83 -30.43% | -5,69 -4,00 -42.25% | 12,4 -3,04 507.57% | -3,13 -2,04 -53.43% | 8,23 -1,11 841.44% | -0,37 0,06 -716.67% | -0,24 -0,07 -242.86% |
Announcement Date | 11/11/21 | 10/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 08/04/23 | 15/05/23 | 14/08/23 |
Past sector events for TherapeuticsMD, Inc.
Today | SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD.: Q4 2023 Earnings Release |
2024-03-22 02:45 am | ECKERT & ZIEGLER SE: Q4 2023 Earnings Release |
2024-03-19 | CHANGCHUN BCHT BIOTECHNOLOGY CO.: Q4 2023 Earnings Release |
2024-03-11 | SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
2024-03-07 01:00 am | MERCK KGAA: Q4 2023 Earnings Release |
2024-02-27 04:05 pm | SUPERNUS PHARMACEUTICALS, INC.: Q4 2023 Earnings Release |
2024-02-22 02:00 am | INDIVIOR PLC: Q4 2023 Earnings Release |
2024-02-21 01:43 am | CALLIDITAS THERAPEUTICS AB: Q4 2023 Earnings Release |
2024-02-14 | DONG-A ST CO., LTD.: Q4 2023 Earnings Release |
2024-02-12 | HK INNO.N CORPORATION: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock TherapeuticsMD, Inc. - Nasdaq
- Calendar TherapeuticsMD, Inc.